To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
4 Current news of Grünenthalrss
Research collaboration to focus on development of novel pain therapeutics
XENTION LTD announced that it has entered into a Research Agreement with the Grünenthal Group. Under the terms of the Agreement, Xention and Grϋnenthal will combine their respective expertise in ion channel drug discovery and pain therapy to collaborate in the identification of new drugs to ...
Alberto Gruahas been appointed Grünenthal Europe and Australia Executive Vice President. Beyond the responsibility of the Grünenthal subsidiaries Grünin both continents, Grua will be also a member of the Group Operating Committee of Grünenthal Corporation. Previously, Grua was Responsible ...
Biofrontera AG and Grünenthal Pharma AG will in the future cooperate on product manufacturing. The companies Biofrontera Pharma GmbH and Grünenthal Pharma AG have signed an agreement for the production of Biofrontera's products BF-200 ALA and Reliéva. BF-200 ALA is a dermatological drug for ...
Navamedic ASA and Grünenthal GmbH have signed the final agreement for marketing and distribution of Glucomed/Flexove in Mexico. On the 22 February 2007, Navamedic ASA announced that it had entered into a Heads of Agreement with Grünenthal for marketing and distribution of Glucomed/Flexove in ...